Mayo Clinic Q and A: How lung restoration improves organ availability
DEAR MAYO CLINIC: I was reading about lung restoration and innovation in the field of lung transplantation. Can you share more about this? ANSWER: Over the past several years, devices outside the body have been used to evaluate human lungs donated for organ transplant before the lungs are transplanted. In the future, lung restoration may increasingly be [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 16, 2021 Category: Databases & Libraries Source Type: news
Scientists Report Creating the First Embryo With Human and Non-Human Primate Cells
In a ground-breaking experiment, researchers have successfully created the first human-monkey chimera. The work, published in the journal Cell, describes the the first embryo containing both human and monkey cells that was cultured for 20 days. Led by Juan Carlos Izpisua Belmonte, the study represents the culmination of decades of work in understanding early embryo development in non-human species, which Belmonte hopes will now apply to humans. But it is bound to raise serious ethical questions about the implications of combining human cells with those from a different species (even if it is a closely related one), and the...
Source: TIME: Health - April 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news
First Living Donor Transplant of Lung Tissue to COVID - 19 Patient Announced
Female recipient received lung tissue donated by her husband and son (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 10, 2021 Category: Respiratory Medicine Tags: Infections, Pulmonology, Surgery, Institutional, Source Type: news
First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced
FRIDAY, April 9, 2021 -- The world ' s first transplant of lung tissue from living donors to a COVID-19 patient with severe lung damage was announced Thursday by doctors in Japan.
In the 11-hour operation at Kyoto University on Wednesday, the female... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2021 Category: Pharmaceuticals Source Type: news
Transplant Saves Selected Patients With Irreversible COVID-19 Lung Disease Transplant Saves Selected Patients With Irreversible COVID-19 Lung Disease
Double lung transplants are the only known way to save the lives of people with acute respiratory distress syndrome and irreversible lung damage from COVID-19, a new study shows.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 9, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
COVID-19 Patient Receives Lung Transplant From Living Donors
TOKYO — Doctors in Japan announced Thursday they have successfully performed the world’s first transplant of lung tissue from living donors to a patient with severe lung damage from COVID-19.
The recipient, identified only as a woman from Japan’s western region of Kansai, is recovering after the nearly 11-hour operation on Wednesday, Kyoto University Hospital said in a statement. It said her husband and son, who donated parts of their lungs, are also in stable condition.
The university said it was the world’s first transplant of lung tissue from living donors to a person with COVID-19 lung damage. T...
Source: TIME: Health - April 9, 2021 Category: Consumer Health News Authors: MARI YAMAGUCHI / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
Moderna vaccine antibodies last at least 6 months; lung transplant can save some COVID-19 survivors
Earlier this month, Pfizer Inc and partner BioNTech SE said their vaccine using similar messenger RNA (mRNA) technology remained highly effective for at least six months. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2021 Category: Pharmaceuticals Source Type: news
COVID-19 patient receives lung transplant from living donors
Doctors in Japan say they have successfully performed the world’s first transplant of lung tissue from living donors to a patient with severe lung damage from COVID-19 (Source: ABC News: Health)
Source: ABC News: Health - April 8, 2021 Category: Consumer Health News Tags: Health Source Type: news
Canada's Hospitals Deploy Artificial Lungs, Scramble for Staff as COVID-19 Hits Younger Patients Canada's Hospitals Deploy Artificial Lungs, Scramble for Staff as COVID-19 Hits Younger Patients
Younger Canadians are bearing the brunt of the nation ' s latest COVID-19 surge, creating growing demand for artificial lungs and a struggle to maintain staffing in critical care units as hospitals make last-ditch efforts to save patients.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 7, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Imbio signs Heart&Lung Health in U.K.
Artificial intelligence software developer Imbio has signed a deal with U.K...Read more on AuntMinnie.comRelated Reading:
Imbio nets FDA nod for RV/LV Analysis AI algorithm
Aidoc and Imbio team up on AI for pulmonary embolism
Siemens adds Imbio AI apps to syngo.via platform
Imbio teams up with Genentech for AI in lung disease
Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news
First US trachea transplant offers hope to Covid patients with windpipe damage
Social worker, 56, treated at Mt Sinai hospital in New YorkSome patients left with serious damage from ventilatorsSurgeons in New York City have performed the first windpipe transplant in the US, giving a woman who suffered severe asthma a new trachea, the tube that transports air from the mouth to the lungs.Doctors say such operations could help Covid-19 patients left with serious windpipe damage from breathing machines.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 6, 2021 Category: Science Authors: Associated Press in New York Tags: Medical research Science US healthcare US news Source Type: news
New Real-World Observational Analysis of UPTRAVI ® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients
SOUTH SAN FRANCISCO, CA – April 6, 2021 – Findings from an analysis of the first 500 patients enrolled in the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry) found more than three-quarters (76%) of pulmonary arterial hypertension (PAH) patients treated with UPTRAVI® (selexipag) either maintained (56%) or reduced (20%) their one-year mortality risk score. The SPHERE results were published in the April issue of the Journal of Heart and Lung Transplantation (JHLT). SPHERE is an ongoing real-world, observational, user registry using two different risk assessment methods that describes the clinical characteristics, ou...
Source: Johnson and Johnson - April 6, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Researchers evaluate deep learning for breast ultrasound
Researchers from China evaluated the use of artificial intelligence (AI) algorithm...Read more on AuntMinnie.comRelated Reading:
Nico.Lab partners with AI Advance for distribution
Radiomics AI algorithm differentiates sclerotic bone lesions
iCAD touts breast screening study
IBM releases chest x-ray dataset for algorithm training
Nines wins FDA clearance for AI lung nodule measurement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news
Criteria for selecting COVID-19 patients for lung lung transplantation
(Medical University of Vienna) The Vienna lung transplantation programme plays a leading role in an international consortium comprising experts from the USA, Europe and Asia. Approximately 40 transplants have now been carried out on Covid-19 patients throughout the world. In a study the consortium has now proposed the first general selection criteria for lung transplantation in Covid-19 patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 2, 2021 Category: International Medicine & Public Health Source Type: news
UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients ’ own blood-forming stem cells.The trial will combine CRISPR technology developed at the Innovative Genomics Institute — a UC Berkeley–UCSF initiative founded by Berkeley’s Nobel Prize–winning scientist Jennifer Doudna — with UCLA’s expertise in genetic analysis and cell manufacturing, and the decades-long expertise at UCSF Benioff Children’s Hos...
Source: UCLA Newsroom: Health Sciences - March 30, 2021 Category: Universities & Medical Training Source Type: news
